The European Health and Digital Executive Agency (HaDEA) has featured Tumor-LN-oC in a special article on its website for World... View Article
As one of the components of the Tumor-LN-oC platform, consortium partner PhosPrint is working on a laser bioprinting process for OrganOnChip (OoC) and sensor applications. PhosPrint representative Simos Papazoglou presented the project progress at SPIE Photonics Europe last week.
Tumor-LN-oC team member Symeon Papazoglou from PhosPrint is presenting his article “Laser bioprinting of cell-laden bioinks for organ-on-chip and sensor... View Article
With the conclusion of Month 10 of the project, Tumor-LN-oC consortium successfully passed the second milestone of the project: the final selection of specifications for materials, processes and user requirements.
To better understand the end-user requirements for the tumor-lymph node-on-chip platform, that will be developed during the course of the project, we have prepared a short questionnaire which you are invited to contribute to!
On the 18th and 19th of November, the Tumor-LN-oC consortium met for the M6 meeting in Athens. The meeting closed... View Article
European (EU) H2020 funded Tumor-LN-oC project, officially started on 1st May, 2021, Tumor-LN-oC proposes the development and validation of tumor-lymph node-on-chip... View Article
On May 7th, 2021 Tumor-LN-oC project (Tumor and Lymph Node on Chip for cancer studies) was officially kicked-offvia online conferencing service where... View Article